Operating Income - GlaxoSmithKline PLC (NYSE:GSK) - Alpha Spread
G

GlaxoSmithKline PLC
NYSE:GSK

Watchlist Manager
GlaxoSmithKline PLC
NYSE:GSK
Watchlist
Price: 38.82 USD 1.17% Market Closed
Market Cap: 79.2B USD
Have any thoughts about
GlaxoSmithKline PLC?
Write Note

GlaxoSmithKline PLC
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

GlaxoSmithKline PLC
Operating Income Peer Comparison

Comparables:
A
AZN
INDV
HIK
AGY
DPH

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
G
GlaxoSmithKline PLC
NYSE:GSK
Operating Income
ÂŁ7.6B
CAGR 3-Years
2%
CAGR 5-Years
-2%
CAGR 10-Years
2%
A
AstraZeneca PLC
NASDAQ:AZN
Operating Income
$10.3B
CAGR 3-Years
34%
CAGR 5-Years
19%
CAGR 10-Years
13%
Indivior PLC
LSE:INDV
Operating Income
$264m
CAGR 3-Years
9%
CAGR 5-Years
-5%
CAGR 10-Years
-9%
Hikma Pharmaceuticals PLC
LSE:HIK
Operating Income
$617m
CAGR 3-Years
4%
CAGR 5-Years
6%
CAGR 10-Years
3%
Allergy Therapeutics PLC
LSE:AGY
Operating Income
-ÂŁ38.8m
CAGR 3-Years
N/A
CAGR 5-Years
-74%
CAGR 10-Years
N/A
Dechra Pharmaceuticals PLC
LSE:DPH
Operating Income
ÂŁ24.9m
CAGR 3-Years
-25%
CAGR 5-Years
-11%
CAGR 10-Years
3%

See Also

What is GlaxoSmithKline PLC's Operating Income?
Operating Income
7.6B GBP

Based on the financial report for Jun 30, 2024, GlaxoSmithKline PLC's Operating Income amounts to 7.6B GBP.

What is GlaxoSmithKline PLC's Operating Income growth rate?
Operating Income CAGR 10Y
2%

Over the last year, the Operating Income growth was -2%. The average annual Operating Income growth rates for GlaxoSmithKline PLC have been 2% over the past three years , -2% over the past five years , and 2% over the past ten years .

Back to Top